Lauren Biscaldi, MS, Managing Editor

Check out a selection of our coverage from Mental Health Awareness Month.

Check out these can’t-miss dermatology stories published this month.

Take a look back at the conference coverage you may have missed this month.

The drug will be available in pharmacies during the second half of 2024.

Test your knowledge of asthma and allergy triggers.

These aflibercept biosimilars are used to treat wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy.

As Women’s Health Week comes to a close, check out some of our recent women’s health coverage. Dive deep into everything from skin care myths to reproductive care access.

Test your pharmacy news knowledge with our weekly quiz.

Dive in and learn more about the answers to yesterday’s quiz.

Test your knowledge of food allergies.

Altuviiio was first granted approval by the FDA in February 2023.

WGc-043 is the first and only vaccine approved for this use.

Test your pharmacy news knowledge with our weekly quiz.

Dive in and learn more about the answers to yesterday’s quiz.

Since biosimilars first launched, unique pricing incentives and strategies have been created to incentives adoption.

One of the biggest issues pharmacists are watching is the Medicare Part D redesign and copay smoothing policy.

Test your knowledge of allergy and asthma clinical guidelines.

Check out this list of resources to share with patients who are experiencing mental health conditions.

The drug, TEV-749, demonstrated statistically significant and clinically meaningful efficacy results.

Check out this list of resources to share with patients who are managing an allergy or asthma diagnosis.

The specialty drug market has exploded in the last few decades.

As medication experts, pharmacists can advocate to organizational decision makers around the benefits of biosimilars.

Data from 2024 are being used as a way to predict what changes may be on the way for 2025.

Mycophenolate mofetil oral suspension is the only FDA-approved ready-to-use liquid formulation.

The market is sensitive to both upstream and downstream pressures that impact drug pricing.

The specialty drug market has exploded, and will continue to grow across sectors such as oncology and neurology.

A lack of clarity around certain provisions of the Inflation Reduction Act has presented challenges to payers.

A siloed approach to care can worsen patient outcomes, but collaboration between one health system specialty pharmacy and a manufacturer led to better patient care.

Understanding the goals of each party is the first step to a successful collaboration.

Collaboration between health system specialty pharmacists and pharmaceutical manufacturers can benefit patients in the long run.